focus -WSS

focus

author：fashion 2025-09-05 11:26:32 - browse：729

ADAM FEUERSTEIN/STAT

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up here.

CHICAGO — It’s only Day 2, but the ASCO meeting is already in full force. That means hordes of oncologists filling the halls, reams of data streaming through the meeting, and incredibly long lines for even the worst food. And STAT reporters Angus Chen, Adam Feuerstein, and Matthew Herper are in the thick of it – on the heels of STAT’s own in-person event here, which was standing room only and came with its own share of thrills, chills, and not a little bit of audience laughter. More on that in a bit.

Here’s a rundown of some of the big news from the first 24 hours of the meeting which, due to some weird kind of relativistic time dilation, represents about a week for our intrepid reporters.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： IVG is promising — but it won’t replace IVF quite yet

Wikipedia

WSS

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Judge denies Trump's request for new trial in E. Jean Carroll case

After a decade, new Gardasil ad campaign gets it (mostly) right

CRISPR base editing slashes cholesterol levels in monkeys

In rare move, senator releases unverified FBI source report alleging Biden bribe

What will Novo Nordisk's VC do with its influx of cash?

leisure time

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Delta passengers in Vegas fall sick while waiting on flight in triple

Walensky prepares to leave CDC — and Congress — behind

A new ‘biological computer' targets cancer while sparing healthy cells

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

How one medical school became remarkably diverse

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

BioMarin wins approval for gene therapy to treat hemophilia A

In rare move, senator releases unverified FBI source report alleging Biden bribe

hotspot

The stock market has soared this year, but will it last? Experts weigh in

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Experts study whether long Covid risk adds up with each reinfection

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

A new ‘biological computer' targets cancer while sparing healthy cells

Wikipedia

leisure time

knowledge

hotspot